The antitrust class action initiated in Michigan against Blue Cross Blue Shield of Michigan has been deemed a “case to watch” by reports as the trial, which is scheduled to begin next year, will offer a rare legal analysis into the effects of so-called most-favored-nation clauses. The lawsuit alleges that BCBS broke antitrust law through such clauses in its contracts, as the agreements ensured that hospitals did not pay more to BCBS competitors. The agreements are gradually becoming outlawed in various states; North Carolina was the latest state to deem the provisions illegal earlier this month. Despite legislative action against the contractual clauses, rarely have they been tested in a court of law. The class action is seeking unspecified damages to compensate for alleged overcharges for consumers as a result of the clauses.
Full Content: Thomson Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
ConocoPhillips Acquires Marathon Oil for $22.5 Billion in Major Energy Sector Consolidation
May 29, 2024 by
CPI
Judge Denies Amazon’s Bid to Dismiss FTC Lawsuit Over Prime Membership Practices
May 29, 2024 by
CPI
Germany and France Advocate for Major EU Competition Reform
May 29, 2024 by
CPI
Equifax Accused of Monopolizing Employment Verification Market in New Suit
May 29, 2024 by
CPI
Car Battery Makers to Challenge EU Cartel Charges in Brussels
May 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Merger Guidelines Retrospective
May 21, 2024 by
CPI
Mergers of Complements
May 21, 2024 by
CPI
Personality Traits, Private Equity, and Merger Analysis
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Lessons in the Importance of Incipiency, Modern Economics, and Monopsony
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Sharpening Merger Analysis
May 21, 2024 by
CPI